Antibody-drug conjugates



January 9, 2019

  • Share
  • Antibody-drug conjugates refer to a highly targeted monoclonal antibody that is conjugated to a cytotoxic antitumor drug through a specific ligation fragment to combine the high selectivity of the antibody with the antitumor activity of the drug. In 2000, the first ADCs drug Mylotarg was approved by the FDA for the treatment of acute myeloid leukemia.

    Drug Discovery

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.